STOCK TITAN

Smartkem SEC Filings

SMTK NASDAQ

Welcome to our dedicated page for Smartkem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

SmartKem, Inc. filings document the public-company record for an organic semiconductor technology developer with common stock listed on Nasdaq under SMTK. The filings cover material-event reports, Securities Act registration statements, notices about annual-report timing, and disclosures tied to its advanced-materials and transistor-backplane business.

Recent regulatory documents address material definitive agreements, convertible notes, preferred stock financings, warrants, private placements, resale registration matters, Nasdaq listing-compliance disclosures, officer and subsidiary governance changes, shareholder voting matters, operating and financial results, and capital-structure updates involving common stock, preferred stock, and warrant securities.

Rhea-AI Summary

SmartKem, Inc. furnished a Form 8‑K announcing it issued a press release covering financial results for the fiscal quarter ended September 30, 2025. The press release is provided as Exhibit 99.1 and incorporated by reference.

The information under Item 2.02 and Exhibit 99.1 is expressly designated as furnished, not filed, under the Exchange Act. The company’s common stock trades on Nasdaq under the symbol SMTK.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.36%
Tags
current report
-
Rhea-AI Summary

SmartKem, Inc. (SMTK) filed its quarterly report and highlighted severe liquidity pressure and operational disruption. The company posted a net loss of $3.9 million for the quarter and $8.5 million year‑to‑date. Cash and cash equivalents were $0.9 million as of September 30, 2025, with net cash used in operating activities of $6.3 million for the nine months.

Accounts payable and accrued expenses rose to $4.9 million, and management disclosed substantial doubt about continuing as a going concern. The company ceased prototyping at CPI following a cost dispute and loss of facility access, and is evaluating alternatives, including ITRI in Taiwan. Subsequent to quarter‑end, SmartKem raised $1.0 million of bridge financing via $1.1 million Senior Secured Notes due April 30, 2026 and issued 400,000 five‑year warrants at an exercise price of $2.75 per share.

SmartKem also signed a non‑binding LOI to pursue an all‑stock combination with Jericho Energy Ventures, envisioning post‑close ownership of 65% Jericho / 35% SmartKem, subject to customary conditions and financing. Shares outstanding were 6,134,963 as of November 11, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.36%
Tags
quarterly report
-
Rhea-AI Summary

SmartKem, Inc. entered into a private placement, issuing senior secured notes with an aggregate principal amount of $1,100,000 and warrants exercisable for up to 400,000 shares at $2.75 per share for an aggregate purchase price of $1,000,000. The notes mature on April 30, 2026, bear no interest unless an event of default occurs (then up to 10% per annum or the legal maximum), and are not convertible.

The company and its subsidiaries granted a security interest in substantially all assets to the collateral agent. The warrants are immediately exercisable, expire five years from issuance, and include cash and, in certain cases more than six months after issuance, cashless exercise; exercises are limited by a 4.99% (or 9.99% at holder election) beneficial ownership cap. Purchasers received piggy-back registration rights.

Separately, the company disclosed it has significantly curtailed operations and delayed vendor payments due to the need for additional capital, with accounts payable increasing significantly since June 30, 2025, and that it will require significant additional capital to pay vendors and resume normal operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

SmartKem, Inc. amended terms with certain holders of securities from its June 2023 private placement. Effective October 13, 2025, the Amendment Agreement lowers the price at which a “Lower Price Issuance” would be deemed to occur, changing it from $4.00 to $2.75. This update modifies when the contract’s pricing provision is triggered under the existing Purchase Agreement dated June 14, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

SmartKem, Inc. reported unregistered equity issuances and a potential strategic transaction. The company agreed to issue up to 500,000 shares of common stock to two consulting firms for investor relations services under an exemption from registration. It also previously issued 10,000 shares on each of July 1, August 1, and September 2, 2025 to vendors as payment for consulting work, also relying on a registration exemption.

The company signed a non-binding letter of intent with Jericho Energy Ventures Inc. for an all-stock business combination in which Jericho stockholders would own 65% and current SmartKem stockholders 35% of the fully diluted equity of the combined company. SmartKem would remain the Nasdaq-listed surviving entity, with Jericho’s chief executive officer leading the combined company and Jericho designating a majority of the board, subject to regulatory requirements. The LOI includes a 60-day exclusivity period and contemplates SmartKem purchasing Jericho common shares from treasury in an amount tied to regaining Nasdaq stockholders’ equity compliance or raising at least $5,000,000, with purchase amounts between $500,000 and $1,000,000. The parties emphasize there is no assurance a definitive agreement or closing will occur due to multiple financing, approval, and diligence conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

SmartKem, Inc. (SMTK) director Joseph Christopher Lizzio reported a sale of 150,000 shares on 09/10/2025 coded as a G transaction (price reported as $0), leaving him with 419,000 shares beneficially owned. The Form 4 was signed 09/25/2025 and indicates the filing is by one reporting person. No derivative transactions or additional details are disclosed in this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

SmartKem, Inc. (SMTK) director Joseph Christopher Lizzio filed an Initial Statement of Beneficial Ownership reporting direct ownership of 569,000 shares of common stock. The event requiring the statement is dated 09/08/2025, and the form is signed on 09/25/2025. The filing is a Form 3 (initial disclosure) indicating the reporting person is a director and the form was filed by one reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Joseph Christopher Lizzio reported beneficial ownership of 419,000 shares of SmartKem, Inc. common stock, representing 7.65% of the outstanding shares as of September 4, 2025. This total includes 180,000 shares held jointly with his spouse; the filing states he does not exercise voting or dispositive power over shares held by his adult children. The percentages are calculated using 5,479,787 shares outstanding based on the issuers SEC filing dated September 5, 2025. The Schedule 13G indicates the holdings were not acquired to influence control of the issuer, and the filing is signed and certified by Mr. Lizzio on September 24, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Insider option grant reported for SmartKem, Inc. (SMTK). Director Melisa Denis was granted a stock option to buy 22,466 shares of common stock at an exercise price of $1.16 per share, with a transaction date of 09/03/2025 and an expiration date of 09/03/2035. The option vests 25% on the grant date and the remaining shares vest in equal monthly installments over 36 months beginning 09/03/2025. The reporting was filed on 09/05/2025 and signed by an attorney-in-fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

SmartKem, Inc. director Klaas de Boer was granted a stock option on 09/03/2025 for 22,466 shares with an exercise price of $1.16. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months commencing on 09/03/2025. The option appears to expire on 09/03/2035. The Form 4 was filed by an attorney-in-fact, Ian Jenks, on 09/05/2025. The reporting person is identified as a director and the filing is made by one reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Smartkem (SMTK) SEC filings are available on StockTitan?

StockTitan tracks 50 SEC filings for Smartkem (SMTK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Smartkem (SMTK)?

The most recent SEC filing for Smartkem (SMTK) was filed on November 13, 2025.